Notícias

CVS Health and Cardinal Health are benefiting from healthcare growth, but differences in performance, valuation and targets shape the outlook.

The firm’s discounted cash-flow valuation applies a 23% cost of equity as TeraWulf moves from bitcoin mining toward contracted AI infrastructure.

LUMN launches Intelligent Internet, offering flexible bandwidth, term-based pricing and security as enterprise AI workloads drive demand.

Oracle just posted 121% cloud growth and a $664 billion backlog, yet the stock sits near a yearly low. Something in the market's math does not add up, and the answer determines whether this is a generational buy or a value trap.

Based on the average brokerage recommendation (ABR), Reddit Inc. (RDDT) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

The average brokerage recommendation (ABR) for Merck (MRK) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

The average brokerage recommendation (ABR) for Archer Aviation (ACHR) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

Based on the average brokerage recommendation (ABR), Quanta Services (PWR) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

Based on the average brokerage recommendation (ABR), Sterling Infrastructure (STRL) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

Based on the average brokerage recommendation (ABR), NextEra (NEE) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

Boston Scientific (BSX) stock has fallen 55.5% over the past twelve months, and at $43.72 it trades barely above its 52-week low of $42.63. The options market now prices a likely one-year range from $28.46 to $67.16 a share. That band is wide, but it is close to how much the stock has already been moving.

The widely followed growth investor keeps making moves.

NuScale Power uses realistic SMR simulation to build operator familiarity with digital controls, reactor behavior and multi-module plant management.

Alibaba's (BABA) stock price is climbing premarket after it rolled out a new AI chip, the Zhenwu V900, pitting it against Nvidia chips as a powerful competitor. The 8:30 hosts, Julie Hyman, Pras Subramanian, and Jake Conley, discuss why it may not be a major threat to Nvidia and why China is focusing more on international markets than on domestic ones.

Morgan Stanley highlighted links between SpaceX and Tesla across AI, energy, connectivity and hardware.

iPhone 18 Pro and Pro Max delivery times are slightly higher than last year in the U.S. and U.K.

Financial stocks were edging higher premarket Tuesday, with the State Street Financial Select Sector

Key TakeawaysD-Wave’s quarterly revenue has stayed inside a roughly $2 million to $4 million band in seven of the last eight quarters, with the $15 million system sale booked in Q1 2025 the lone exception, even as management points to a 59% jump in Q2 bookings and 668% growth in remaining performance obligations. Total operating expenses climbed from $21.

Frontline (NYSE:FRO) announced that its Board has approved a special one time cash dividend alongside its regular Q2 2026 payout. The extra distribution is described as a single event, separate from the tanker operator's usual recurring dividend policy. Management framed the special dividend as a direct cash return to shareholders that reflects the group's current financial position. This special one time dividend for the second quarter of 2026 is an important development to weigh against...

Johnson & Johnson (NYSE: JNJ) received FDA approval for ICOTYDE (icotrokinra) to treat moderate to severe plaque psoriasis in the U.S. ICOTYDE targets the IL-23 receptor and is in Phase III clinical trials for a potential psoriatic arthritis indication. The new therapy extends Johnson & Johnson's immunology pipeline beyond oncology and MedTech into chronic inflammatory skin and joint conditions. The ICOTYDE psoriasis approval and psoriatic arthritis Phase III program deserves weighing...

Alibaba is scaling its AI models, chips and data centers as Chinese tech companies race to build alternatives to Nvidia.

TMC the metals (NasdaqGS:TMC) is stepping in front of investors again, with management presenting at Morgan Stanley's 14th Annual Laguna Conference on September 15 and the Water Tower Research Virtual Insights Conference on September 22. Recent trading has been choppy for TMC the metals, with a 1-day share price return of 9.52% and a 7-day share price return of 8.09% following a 30-day share price return that declined 13.57%. That near term volatility sits against a year to date share price...

The 8:30 Hosts Julie Hyman, Pras Subramanian, and Jake Conley discuss the growing opposition to AI data centers in US communities.

The block protects platform control while potentially surrendering orders initiated by outside agents.

Axcelis Technologies has announced plans to invest US$35,000,000 in a new 200,000-square-foot ion implantation equipment manufacturing facility in Pyeongtaek, Korea, with integrated cleanrooms, warehousing, and training capabilities, following an investment declaration ceremony with Korean government bodies and production targeted to start in the second half of 2028. This expansion adds a significant Asian manufacturing hub that could enhance Axcelis’s ability to respond quickly to customer...

Carnival Corporation (CCL) looks undervalued to value investors ahead of its Q3 earnings release next Tuesday (29th). For example, its forward P/E ratio is just 10x, versus an average of 13x over the last 2 years.

On Holding is betting on sneakers, apparel and an expansion into soccer and golf to drive high-teens annual sales growth through 2029 while maintaining its pricing strategy.

US stock futures were mixed on Tuesday following strong gains in the previous session, as investors assessed geopolitical developments and another decline in oil prices. Dow Jones Industrial Average futures rose 0.

China’s Cyberspace Administration reportedly summoned representatives from all seven Chinese companies named in Anthropic’s report before narrowing its focus to DeepSeek and Moonshot.

NVIDIA returns to Zacks Rank #1 as strong AI-driven growth and rising estimates contrast with Travelzoo's earnings and membership challenges.